{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:23:08Z","timestamp":1782764588889,"version":"3.54.5"},"reference-count":20,"publisher":"The Journal of Rheumatology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2017,5,10]]},"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To date, there are no standardized disease activity tools for systemic juvenile idiopathic arthritis (sJIA). We developed a core set of disease activity measures for sJIA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We conducted a validation study in patients with sJIA recruited from 3 Canadian institutions. Disease activity scores were based on questionnaires, clinical factors, and laboratory measures. The physician\u2019s global assessment was our criterion standard. We determined the strength of association of each item with the criterion standard. We then surveyed international experts to determine the top 10 items. Finally, we used the experts\u2019 responses to generate a proposed core set of disease activity measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>We enrolled 57 subjects \u2014 26 with moderately or severely active disease, and 31 with mildly active or inactive disease. Items that most strongly correlated with the criterion standard were number of active joints (r = 0.79), parent\u2019s global assessment of disease activity (r = 0.53), erythrocyte sedimentation rate (ESR; r = 0.62), and C-reactive protein (CRP; r = 0.61). The response rate from international experts was 82% (154\/187). Items with the most votes, in descending order, were number of active joints, number of days with fever in the preceding 2 weeks, patient\u2019s and parent\u2019s global assessments of disease activity, sJIA rash, ESR, CRP, and hemoglobin level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>We propose a core set of items for measuring disease activity in sJIA. Future research should be aimed at further validation of this core set in the international context.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.161534","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:20:23Z","timestamp":1501633223000},"page":"115-121","source":"Crossref","is-referenced-by-count":11,"title":["Proposed Core Set of Items for Measuring Disease Activity in Systemic Juvenile Idiopathic Arthritis"],"prefix":"10.3899","volume":"45","author":[{"given":"Elizaveta","family":"Limenis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Achonu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Batthish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Mclimont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athimalaipet","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Scuccimarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayfel","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"2025062500201656000_45.1.115.1","doi-asserted-by":"crossref","unstructured":"De Benedetti F Schneider R . Systemic juvenile idiopathic arthritis. In: Cassidy J Petty R Laxer RM , editors. Textbook of pediatric rheumatology. 7th ed. Philadelphia: Saunders; 2016.","DOI":"10.1016\/B978-0-323-24145-8.00016-8"},{"key":"2025062500201656000_45.1.115.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.07.022"},{"key":"2025062500201656000_45.1.115.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.21774"},{"key":"2025062500201656000_45.1.115.4","first-page":"337","article-title":"Analysis of disease activity, functional disability and articular damage in patients with juvenile idiopathic arthritis: a prospective outcome study","volume":"29","author":"Susic","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"2025062500201656000_45.1.115.5","doi-asserted-by":"crossref","first-page":"715352","DOI":"10.1155\/2013\/715352","article-title":"Disease activity measures in pediatric rheumatic diseases","volume":"2013","author":"Luca","year":"2013","journal-title":"Int J Rheumatol"},{"key":"2025062500201656000_45.1.115.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.57.1.38"},{"key":"2025062500201656000_45.1.115.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205099"},{"key":"2025062500201656000_45.1.115.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112802"},{"key":"2025062500201656000_45.1.115.9","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/art.38699","article-title":"The RAndomized Placebo Phase Study Of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis (RAPPORT)","volume":"66","author":"Ilowite","year":"2004","journal-title":"Arthritis Rheumatol"},{"key":"2025062500201656000_45.1.115.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.24516"},{"key":"2025062500201656000_45.1.115.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.38984"},{"key":"2025062500201656000_45.1.115.12","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20497"},{"key":"2025062500201656000_45.1.115.13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh597"},{"key":"2025062500201656000_45.1.115.14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei095"},{"key":"2025062500201656000_45.1.115.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780371209"},{"key":"2025062500201656000_45.1.115.16","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-9-9"},{"key":"2025062500201656000_45.1.115.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.03.007"},{"key":"2025062500201656000_45.1.115.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200598"},{"key":"2025062500201656000_45.1.115.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.24137"},{"key":"2025062500201656000_45.1.115.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.06.005"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.161534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T07:20:27Z","timestamp":1750836027000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.161534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,1]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.3899\/jrheum.161534"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.161534","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}